Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07866443 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Combination of Pregabalin and Trigger Point Injection With Ropivacaine in the Treatment of Myofascial Pain Syndrome of the Neck and Upper Back.

StatusCompleted
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study compared trigger point injections with ropivacaine alone versus trigger point injections combined with oral pregabalin in adults with chronic myofascial pain of the neck and upper back. Participants were randomly assigned to one of the two treatment groups. Pain intensity, number of trigger points, neuropathic pain symptoms, and health-related quality of life were assessed at baseline and at 1 and 3 months after treatment.
Trial Details
NCT Number NCT07866443
Lead Sponsor National and Kapodistrian University of Athens
Conditions Myofascial Pain Syndrome - Neck
Enrollment 74 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov